Category: IPO

All News on IPO

IPO

Sichuan Biokin Pharmaceutical Hong Kong IPO: Innovative Oncology Drugs, Global Expansion & Key Financials (2025)

minichart

January 11, 2026

Baili Pharmaceutical IPO Analysis: Key Details, Financials, Risks, and Outlook Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical Hong Kong IPO: Strategic Growth in Oncology, Financials, and Investor Outlook IPO...

Continue Reading 0

IPO

Sichuan Biokin Pharmaceutical Global Offering 2025: Hong Kong IPO Details, Application Process & Key Dates

minichart

January 11, 2026

Sichuan Biokin Pharmaceutical Co., Ltd. IPO Analysis Company Name: Sichuan Biokin Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Sichuan Biokin Pharmaceutical IPO: In-Depth Analysis, Offer Details, and Investor Insights Sichuan Biokin Pharmaceutical...

Continue Reading 0

IPO

Japanese Pachinko & Real Estate Company IPO: Business Model, Market Strategies, and Investment Highlights for 2025

minichart

January 4, 2026

Libera IPO Analysis June 2025: Investment Opportunity, Financials, and Growth Outlook Libera Date of prospectus: June 2025 Libera IPO: High-Growth Japanese Tech Play Targets Nasdaq – Key Risks, Upside, and Investment Facts Libera, a...

Continue Reading 0

IPO

Jinxun Group Hong Kong IPO: Global Copper & Cobalt Leader, ESG, Financials & Growth Strategy Explained

minichart

January 4, 2026

Yunnan Jinxun Resources Co., Ltd. IPO Analysis: Investor-Grade Deep Dive Yunnan Jinxun Resources Co., Ltd. Date of Prospectus: December 31, 2025 Yunnan Jinxun Resources: HKEX IPO Analysis, Cornerstone Investors, Offer Structure, and First-Day Listing...

Continue Reading 0

Hong Kong stocksIPO

Suzhou Ribo Life Science IPO: Leading the Future of siRNA Oligonucleotide Therapeutics – Company Overview, Pipeline, and Competitive Edge 1116272278

minichart

January 4, 2026

Suzhou Ribo Life Science Co., Ltd. IPO: Investor Analysis & Outlook Suzhou Ribo Life Science Co., Ltd. Date of prospectus: December 31, 2025 Suzhou Ribo Life Science IPO: In-Depth Analysis, Investor Insights & Listing...

Continue Reading 0

IPO

MiniMax AI: Global Leader in Scalable Multi-Modal Foundation Models, Video Generation, and AI-Native Products

minichart

January 4, 2026

MiniMax Limited IPO Analysis: Comprehensive Investor Guide MiniMax Limited Date of Prospectus: December 31, 2025 MiniMax Limited IPO: A Deep Dive into the Largest AI Foundation Model Listing in Hong Kong MiniMax Limited, a...

Continue Reading 0

IPO

Suzhou Ribo Life Science Co., Ltd. Global Offering: Hong Kong IPO Details, Application Process & Key Dates for 2026 2

minichart

January 4, 2026

Suzhou Ribo Life Science Co., Ltd. IPO Analysis: Comprehensive Investor Insights Company: Suzhou Ribo Life Science Co., Ltd. Date of Prospectus: December 31, 2025 Suzhou Ribo Life Science Co., Ltd. IPO: Detailed Analysis of...

Continue Reading 0

IPO

Yunnan Jinxun Resources Co., Ltd. Global Offering: Key Dates, Application Process & IPO Details (Stock Code: 3636) 2

minichart

January 4, 2026

Yunnan Jinxun Resources Co., Ltd. IPO Analysis – 2025/2026 Hong Kong Listing Deep Dive Yunnan Jinxun Resources Co., Ltd. Date of prospectus: December 31, 2025 Yunnan Jinxun Resources Co., Ltd. Launches Hong Kong IPO:...

Continue Reading 0

IPO

MiniMax Group Inc. Announces Hong Kong IPO: Key Dates, Offer Details & Application Guide for 2026 Listing 2610

minichart

January 4, 2026

MiniMax Group Inc. Launches Landmark Hong Kong IPO: Key Details, Structure, and Investor Insights MiniMax Group Inc., a Cayman Islands-incorporated company controlled through weighted voting rights, is set to launch its highly anticipated initial...

Continue Reading 0

IPO

Edge Medical: China’s Leading Surgical Robot Innovator – Products, Market Strategy, and Competitive Advantages Explained

minichart

January 4, 2026

Shenzhen Edge Medical Co., Ltd. IPO Analysis – Robust Investor Overview Shenzhen Edge Medical Co., Ltd. Date of Prospectus: December 30, 2025 Shenzhen Edge Medical’s Landmark Hong Kong IPO: Investor Analysis, Financials, and Strategic...

Continue Reading 0